Literature DB >> 14662266

Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice.

Kanjo Yamamoto1, Tetsuo Shioi, Koji Uchiyama, Tadashi Miyamoto, Shigetake Sasayama, Akira Matsumori.   

Abstract

OBJECTIVES: This study examined the role of angiotensin II (Ang-II) in a murine model of viral myocarditis.
BACKGROUND: Ang-II plays an important role in the pathophysiology of various cardiovascular disorders. However, the role of Ang-II in inflammatory heart diseases is not known.
METHODS: Four-week-old wild-type (WT) and Ang-II type 1 receptor (AT(1)R) knockout (KO) mice were inoculated with the encephalomyocarditis virus (EMCV). Survival, histopathology, expression of proinflammatory cytokines, and activity of nuclear factor-kappa B (NF-kB) in the heart were examined.
RESULTS: The 14-day survival was significantly increased in KO compared with WT mice. Histopathologic scores for myocardial necrosis (0.86 +/- 0.69 vs. 2.44 +/- 0.88, p < 0.01) and cellular infiltration (0.86 +/- 0.38 vs. 2.33 +/- 0.50, p < 0.01) were lower in KO than in WT mice. The expression of tumor necrosis factor-alpha (TNF-alpha) was increased 43.2-fold, that of interleukin-1-beta (IL-1-beta) 45.8-fold, and the activity of NF-kB 2.24-fold by EMCV inoculation in WT mice (each p < 0.01), but not in KO mice (5.9-fold, 6.3-fold, and 1.12-fold, respectively, each p = NS). The AT(1)R blocker also significantly attenuated the expression of proinflammatory cytokines and the activation of NF-kB in virus-inoculated WT mice. Intravenous Ang-II injection enhanced the activation of NF-kB (2.28-fold, p < 0.01) and increased the expression of TNF-alpha (2.31-fold, p < 0.01) and IL-1-beta (2.45-fold, p < 0.01) in heart tissue of WT but not KO mice.
CONCLUSIONS: These results indicate that the AT(1)R signal is obligatory for the development of virus-induced myocardial injury through the proinflammatory action of Ang-II via the NF-kB/cytokine pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662266     DOI: 10.1016/j.jacc.2003.07.021

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  CBP knockdown inhibits angiotensin II-induced vascular smooth muscle cells proliferation through downregulating NF-kB transcriptional activity.

Authors:  Jian Yang; Hong Jiang; Si-si Chen; Jing Chen; Sheng-kai Xu; Wan-qiang Li; Ji-chun Wang
Journal:  Mol Cell Biochem       Date:  2010-02-16       Impact factor: 3.396

2.  Cardiomyocyte-specific IκB kinase (IKK)/NF-κB activation induces reversible inflammatory cardiomyopathy and heart failure.

Authors:  Harald J Maier; Tobias G Schips; Astrid Wietelmann; Marcus Krüger; Cornelia Brunner; Martina Sauter; Karin Klingel; Thomas Böttger; Thomas Braun; Thomas Wirth
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

3.  Lessons learned from experimental myocarditis.

Authors:  A Matsumori
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

4.  Cardiac cell-specific apoptotic and cytokine responses to reovirus infection: determinants of myocarditic phenotype.

Authors:  Shelley D Miyamoto; R D Brown; Bridget A Robinson; Kenneth L Tyler; Carlin S Long; Roberta L Debiasi
Journal:  J Card Fail       Date:  2009-03-03       Impact factor: 5.712

5.  Substance P is required for the pathogenesis of EMCV infection in mice.

Authors:  Prema Robinson; Armandina Garza; Jeffrey Moore; T Kris Eckols; Skakun Parti; Vishwanathan Balaji; Jesus Vallejo; David J Tweardy
Journal:  Int J Clin Exp Med       Date:  2009-03-31

6.  Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition.

Authors:  Ariel U Spencer; Hua Yang; Emir Q Haxhija; Barbara E Wildhaber; Joel K Greenson; Daniel H Teitelbaum
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

7.  Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.

Authors:  Konstantinos Savvatis; Sophie van Linthout; Kapka Miteva; Kathleen Pappritz; Dirk Westermann; Joerg C Schefold; Gerhard Fusch; Alice Weithäuser; Ursula Rauch; Peter-Moritz Becher; Karin Klingel; Jochen Ringe; Andreas Kurtz; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

8.  High susceptibility to lipopolysaccharide-induced lethal shock in encephalomyocarditis virus-infected mice.

Authors:  Hirofumi Ohtaki; Hiroyasu Ito; Masato Hoshi; Yosuke Osawa; Manabu Takamatsu; Akira Hara; Tetsuya Ishikawa; Hisataka Moriwaki; Kuniaki Saito; Mitsuru Seishima
Journal:  Sci Rep       Date:  2012-04-16       Impact factor: 4.379

9.  The effects of losartan on cytomegalovirus infection in human trabecular meshwork cells.

Authors:  Jin A Choi; Ju-Eun Kim; Hyun-Hee Ju; Jiyoung Lee; Donghyun Jee; Chan Kee Park; Soon-Young Paik
Journal:  PLoS One       Date:  2019-06-19       Impact factor: 3.240

10.  Cardiac-Specific Activation of IKK2 Leads to Defects in Heart Development and Embryonic Lethality.

Authors:  Bärbel Kraut; Harald J Maier; Enikö Kókai; Katja Fiedler; Thomas Boettger; Annett Illing; Sawa Kostin; Paul Walther; Thomas Braun; Thomas Wirth
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.